von Metzler I - Search Results

1

Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene.

Clees AS, Stolp V, Häupl B, Fuhrmann DC, Wempe F, Seibert M, Weber S, Banning A, Tikkanen R, Williams R, Brüne B, Serve H, Schnütgen F, von Metzler I, Kurrle N. Clees AS, et al. Among authors: von metzler i. Cells. 2022 Jan 15;11(2):292. doi: 10.3390/cells11020292. Cells. 2022. PMID: 35053409 Free PMC article.

2

Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma.

Tognarelli S, Wirsching S, von Metzler I, Rais B, Jacobs B, Serve H, Bader P, Ullrich E. Tognarelli S, et al. Among authors: von metzler i. Front Immunol. 2018 Nov 27;9:2743. doi: 10.3389/fimmu.2018.02743. eCollection 2018. Front Immunol. 2018. PMID: 30542346 Free PMC article.

3

High CD34 positive stem cell dosage improves thrombocyte recovery in obese myeloma patients undergoing autologous stem cell transplantation.

Enßle JC, Wolf S, von Metzler I, Weber S, Bialleck H, Seifried E, Serve H, Scheich S, Steffen B. Enßle JC, et al. Among authors: von metzler i. Leuk Lymphoma. 2021 Dec;62(13):3283-3287. doi: 10.1080/10428194.2021.1950707. Epub 2021 Jul 13. Leuk Lymphoma. 2021. PMID: 34254876 No abstract available.

4

COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view.

von Metzler I, Campe J, Huenecke S, Raab MS, Goldschmidt H, Schubert R, Rabenau HF, Ciesek S, Serve H, Ullrich E. von Metzler I, et al. J Mol Med (Berl). 2022 Mar;100(3):463-470. doi: 10.1007/s00109-021-02114-x. Epub 2021 Oct 18. J Mol Med (Berl). 2022. PMID: 34657968 Free PMC article.

5

Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma.

Enssle JC, Campe J, Büchel S, Moter A, See F, Grießbaum K, Rieger MA, Wolf S, Ballo O, Steffen B, Serve H, Rabenau HF, Widera M, Bremm M, Huenecke S, Ciesek S, von Metzler I, Ullrich E. Enssle JC, et al. Among authors: von metzler i. Cancer Cell. 2022 Jun 13;40(6):587-589. doi: 10.1016/j.ccell.2022.05.003. Epub 2022 May 8. Cancer Cell. 2022. PMID: 35588736 Free PMC article. No abstract available.

6

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma.

Bexte T, Alzubi J, Reindl LM, Wendel P, Schubert R, Salzmann-Manrique E, von Metzler I, Cathomen T, Ullrich E. Bexte T, et al. Among authors: von metzler i. Oncoimmunology. 2022 May 31;11(1):2081415. doi: 10.1080/2162402X.2022.2081415. eCollection 2022. Oncoimmunology. 2022. PMID: 35694192 Free PMC article.

7

Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients.

Enssle JC, Campe J, Moter A, Voit I, Gessner A, Yu W, Wolf S, Steffen B, Serve H, Bremm M, Huenecke S, Lohoff M, Vehreschild M, Rabenau HF, Widera M, Ciesek S, Oellerich T, Imkeller K, Rieger MA, von Metzler I, Ullrich E. Enssle JC, et al. Among authors: von metzler i. Leukemia. 2024 Jan;38(1):168-180. doi: 10.1038/s41375-023-02070-0. Epub 2023 Dec 4. Leukemia. 2024. PMID: 38049509 Free PMC article.

8

Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.

von Metzler I, Heider U, Mieth M, Lamottke B, Kaiser M, Jakob C, Sezer O. von Metzler I, et al. Exp Cell Res. 2009 Aug 15;315(14):2471-8. doi: 10.1016/j.yexcr.2009.04.019. Epub 2009 May 3. Exp Cell Res. 2009. PMID: 19410573

9

Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.

Kaiser M, Lamottke B, Mieth M, Jensen MR, Quadt C, Garcia-Echeverria C, Atadja P, Heider U, von Metzler I, Türkmen S, Sezer O. Kaiser M, et al. Among authors: von metzler i. Eur J Haematol. 2010 Apr;84(4):337-44. doi: 10.1111/j.1600-0609.2009.01403.x. Epub 2009 Dec 17. Eur J Haematol. 2010. PMID: 20028416

10

Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study.

Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, Brunnberg U, Brandts C, Ballo O, von Metzler I, Kessel J, Serve H, Steffen B. Scheich S, et al. Among authors: von metzler i. Biol Blood Marrow Transplant. 2017 Sep;23(9):1455-1462. doi: 10.1016/j.bbmt.2017.05.016. Epub 2017 May 18. Biol Blood Marrow Transplant. 2017. PMID: 28528711 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page